Ameritas Investment Partners, Inc. Ardelyx, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 23,865 shares of ARDX stock, worth $176,839. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,865
Previous 23,865
-0.0%
Holding current value
$176,839
Previous $147,000
18.37%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ARDX
# of Institutions
197Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$163 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$99.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$50.5 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $1.15B
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...